Gilead Sciences Inc at Citi Global Healthcare Conference Transcript
Good morning. Welcome to the Citi Global Healthcare Conference continuing this morning. Next up we have Gilead Sciences, and with us today, we're pleased to have Andy Dickinson, CFO. Welcome.
Thank you. Thanks for having us again. I appreciate it.
Of course. But we start this way. Maybe give a couple of minutes to give some opening remarks, and then we'll go over some questions.
Sure, yeah. Maybe four things to highlight as we start. One, we've had a terrific 2025 so far. You see that in our third quarter results. We increased our guidance for the year. So we can talk about that specifically. But a great, great first three quarters of the year carrying a lot of momentum in our business overall. You see, the second thing I would highlight is the really strong durable portfolio. So our base business led by our two
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
